Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention

Aim. To identify predictors of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).Material and methods. This prospective single-center study included 225 patients with stable CAD requiring drug-eluting stent implan...

Full description

Bibliographic Details
Main Authors: A. V. Svarovskaya, E. A. Kuzheleva, A. A. Arzhanik, V. A. Fediunina, V. A. Aleksandrenko, A. D. Starchenko, A. A. Garganeeva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2020-07-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3938
id doaj-d54615be09df455b8143add6764c17bb
record_format Article
spelling doaj-d54615be09df455b8143add6764c17bb2021-07-28T14:02:39Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202020-07-0125610.15829/1560-4071-2020-39382976Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary interventionA. V. Svarovskaya0E. A. Kuzheleva1A. A. Arzhanik2V. A. Fediunina3V. A. Aleksandrenko4A. D. Starchenko5A. A. Garganeeva6Cardiology Research Institute, Tomsk National Research Medical CentreCardiology Research Institute, Tomsk National Research Medical CentreSaint Petersburg State UniversityCardiology Research Institute, Tomsk National Research Medical centerCardiology Research Institute, Tomsk National Research Medical centerRegional Sol Center for Medical RehabilitationCardiology Research Institute, Tomsk National Research Medical centerAim. To identify predictors of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).Material and methods. This prospective single-center study included 225 patients with stable CAD requiring drug-eluting stent implantation. The average follow-up period for patients was 14,5 (6;23) months. Levels of glycated hemoglobin (HbA1c), insulin, tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), interleukin-10 (IL-10), endothelin-1 (ET-1) and the serum lipid profile were evaluated. Insulin resistance was assessed by the HOMA-IR index. The patients were divided into 2 groups: group 1 (n=98) — patients with MACE, group 2 (n=127) — patients without MACE over the follow-up period.Results. During the follow-up period, MACE were recorded in 43,5% of patients, of which: fatal outcome in 3 (3,1%) patients, acute coronary syndrome (ACS) — 14 (14,3%), decompensated heart failure (HF) — 8 (8,2%), non-fatal myocardial infarc tion (MI) — 4 (4,1%), stroke — 3 (3,1%), in-stent restenosis — 18 (18,4%), target vessel revascularization due to progression of atherosclerosis — 25 (25,4%), lifethreatening arrhythmias — 18 (18,4%), implantation of a cardiac resynchronization therapy defibrillator — 5 (5%). To determine critical levels for quantitative predictors, ROC curves were created with threshold values that increase the likelihood of MACE.Conclusion. As a result of the study, we found that the waist-to-hip ratio >1,0495, the HOMA-IR index >3,13 and the endothelin-1 >0,75 mmol/L are independent predictors of unfavorable prognosis in patients with CAD after PCI.https://russjcardiol.elpub.ru/jour/article/view/3938endothelin-1coronary heart diseasemyocardial revascularizationprognosisinsulin resistanceobesity
collection DOAJ
language Russian
format Article
sources DOAJ
author A. V. Svarovskaya
E. A. Kuzheleva
A. A. Arzhanik
V. A. Fediunina
V. A. Aleksandrenko
A. D. Starchenko
A. A. Garganeeva
spellingShingle A. V. Svarovskaya
E. A. Kuzheleva
A. A. Arzhanik
V. A. Fediunina
V. A. Aleksandrenko
A. D. Starchenko
A. A. Garganeeva
Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
Российский кардиологический журнал
endothelin-1
coronary heart disease
myocardial revascularization
prognosis
insulin resistance
obesity
author_facet A. V. Svarovskaya
E. A. Kuzheleva
A. A. Arzhanik
V. A. Fediunina
V. A. Aleksandrenko
A. D. Starchenko
A. A. Garganeeva
author_sort A. V. Svarovskaya
title Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
title_short Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
title_full Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
title_fullStr Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
title_full_unstemmed Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
title_sort predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2020-07-01
description Aim. To identify predictors of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).Material and methods. This prospective single-center study included 225 patients with stable CAD requiring drug-eluting stent implantation. The average follow-up period for patients was 14,5 (6;23) months. Levels of glycated hemoglobin (HbA1c), insulin, tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), interleukin-10 (IL-10), endothelin-1 (ET-1) and the serum lipid profile were evaluated. Insulin resistance was assessed by the HOMA-IR index. The patients were divided into 2 groups: group 1 (n=98) — patients with MACE, group 2 (n=127) — patients without MACE over the follow-up period.Results. During the follow-up period, MACE were recorded in 43,5% of patients, of which: fatal outcome in 3 (3,1%) patients, acute coronary syndrome (ACS) — 14 (14,3%), decompensated heart failure (HF) — 8 (8,2%), non-fatal myocardial infarc tion (MI) — 4 (4,1%), stroke — 3 (3,1%), in-stent restenosis — 18 (18,4%), target vessel revascularization due to progression of atherosclerosis — 25 (25,4%), lifethreatening arrhythmias — 18 (18,4%), implantation of a cardiac resynchronization therapy defibrillator — 5 (5%). To determine critical levels for quantitative predictors, ROC curves were created with threshold values that increase the likelihood of MACE.Conclusion. As a result of the study, we found that the waist-to-hip ratio >1,0495, the HOMA-IR index >3,13 and the endothelin-1 >0,75 mmol/L are independent predictors of unfavorable prognosis in patients with CAD after PCI.
topic endothelin-1
coronary heart disease
myocardial revascularization
prognosis
insulin resistance
obesity
url https://russjcardiol.elpub.ru/jour/article/view/3938
work_keys_str_mv AT avsvarovskaya predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT eakuzheleva predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT aaarzhanik predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT vafediunina predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT vaaleksandrenko predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT adstarchenko predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
AT aagarganeeva predictorsofadversecardiovasculareventsinpatientswithcoronaryarterydiseaseafterpercutaneouscoronaryintervention
_version_ 1721268938160996352